| Income Statement |
| Total Revenue | 25.21K |
|
| Revenues (USD) | 25.21K |
| Cost of Revenue | 16.91K |
| Gross Profit | 8.30K |
| Operating Expenses | 2.91M |
| Research and Development Expense | 297.07K |
| Selling, General and Administrative Expense | 2.61M |
| Operating Income | -2.90M |
| Net Income | -2.75M |
| Net Income Common Stock | -2.75M |
| Net Income Common Stock (USD) | -2.75M |
| Consolidated Income | -2.75M |
| Earnings per Basic Share | -1.12 |
| Earnings per Basic Share (USD) | -1.12 |
| Earnings per Diluted Share | -1.12 |
| Earning Before Interest & Taxes (EBIT) | -2.75M |
| Earning Before Interest & Taxes (USD) | -2.75M |
| Weighted Average Shares | 2.46M |
| Weighted Average Shares Diluted | 2.46M |
| Balance Sheet |
| Cash and Equivalents | 16.31M |
| Cash and Equivalents (USD) | 16.31M |
| Trade and Non-Trade Receivables | 28.17K |
| Current Assets | 16.79M |
| Property, Plant & Equipment Net | 23.23K |
| Total Assets | 18.04M |
| Current Liabilities | 1.04M |
| Total Liabilities | 1.04M |
| Accumulated Retained Earnings (Deficit) | -64.10M |
| Shareholders Equity | 17.00M |
| Shareholders Equity (USD) | 17.00M |
| Assets Non-Current | 1.25M |
| Goodwill and Intangible Assets | 1.22M |
| Trade and Non-Trade Payables | 704.98K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 61.87K |
| Net Cash Flow from Financing | -19.28K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.72M |
| Capital Expenditure | -1.81K |
| Issuance (Purchase) of Equity Shares | -19.28K |
| Net Cash Flow from Investing | -43.18K |
| Net Cash Flow from Operations | -2.66M |
| Share Based Compensation | 102.12K |